Kanceftri S 125mg/62.5mg Injection
Marketer
Fortune Life Sciences Private Limited
Salt Composition
Ceftriaxone (125mg) + Sulbactam (62.5mg)
Overview Kanceftri S 125mg/62.5mg Injection
Kanceftri S 125mg/62.5mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, halting infection spread. Administration must always be under a physician's guidance; adhere strictly to the prescribed schedule. Complete the entire treatment course, regardless of symptom improvement; premature cessation may compromise effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (skin rashes, itching, swelling, respiratory distress). Inform your doctor of all current medications, especially if you are pregnant, breastfeeding, or have pre-existing conditions. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid operating vehicles if experiencing somnolence or dizziness. Rest, proper nutrition, and adequate hydration are crucial for optimal recovery. Your doctor might order tests to monitor the medicine's impact.
Uses of Kanceftri S 125mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Kanceftri S 125mg/62.5mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Kanceftri S 125mg/62.5mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Kanceftri S 125mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Kanceftri S 125mg/62.5mg Injection works:
Ceftriaxone and Sulbactam, combined as Kanceftri S 125mg/62.5mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a potent antibiotic, disrupts bacterial cell wall synthesis, compromising their survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Kanceftri S 125mg/62.5mg Injection may be taken with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Kanceftri S (125mg/62.5mg) is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nonetheless, data from human trials remain scarce.
Breast feedingCAUTION
Administering Kanceftri S 125mg/62.5mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The injection Kanceftri S 125mg/62.5mg can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Kanceftri S 125mg/62.5mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Patients with severe hepatic impairment should use Kanceftri S 125mg/62.5mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Kanceftri S 125mg/62.5mg Injection is unnecessary in individuals with mild to moderate liver dysfunction.
What if you forget to take Kanceftri S 125mg/62.5mg Injection :
Omitting a scheduled dose of Kanceftri S 125mg/62.5mg Injection necessitates contacting your physician.
Facts to Know About Kanceftri S 125mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently